Overview of Virbac's Share Structure
Virbac, a global leader in animal health, is dedicated to enhancing the well-being of various animal species through innovative health solutions. As part of its commitment to shareholders and stakeholders, Virbac regularly discloses updated information on its share structure and voting rights, ensuring transparency in its corporate governance practices.
Key Information for Shareholders
According to the recent declaration, as of November 30, 2025, Virbac recorded a total of 8,390,660 shares that represent its share capital. These shares correspond to a gross total of 12,704,542 voting rights. However, when accounting for shares without voting rights, the net total of voting rights is slightly less, standing at 12,691,706. This distinction is crucial for investors and stakeholders who are keen on understanding their voting influence at company meetings.
Importance of Voting Rights
Voting rights are a significant aspect of corporate structure, as they empower shareholders to influence company decisions, including the election of board members and approval of major corporate actions. In the case of Virbac, maintaining a healthy ratio of voting rights to shares underlines the company's dedication to shareholder engagement, reflecting a balanced power structure.
Virbac's Market Presence
Listed on Euronext Paris under the ticker Paris:VIRP, Virbac continues to offer a diverse range of products and solutions aimed at animal health. The company's presence on a prominent stock exchange not only enhances its visibility but also allows investors to engage more actively with the company’s developments.
Contact Information for Stakeholders
Investors and stakeholders can easily reach out for inquiries or further information. Corporate Finance at Virbac can be contacted at tel. 33 4 92 08 71 32 or through the email address finances@virbac.com. For more detailed insights, potential investors can explore Virbac’s official website at www.virbac.com.
Conclusion
In conclusion, the information regarding the number of shares and voting rights is vital for all stakeholders involved with Virbac. As the company continues to shape the future of animal health through innovative solutions and responsible corporate governance, understanding these metrics helps ensure that investors are well-informed. With an impressive commitment to animal health and transparent operations, Virbac remains a pivotal player in its industry.
Frequently Asked Questions
What is the total number of shares for Virbac?
The total number of shares for Virbac is 8,390,660.
How many voting rights does each share confer?
Each share confers voting rights, resulting in a gross total of 12,704,542 voting rights, adjusting for shares without voting rights.
Where is Virbac listed?
Virbac is listed on Euronext Paris under the ticker Paris:VIRP.
How can shareholders contact Virbac for inquiries?
Shareholders can contact Virbac via phone at tel. 33 4 92 08 71 32 or email finances@virbac.com.
What sector does Virbac operate in?
Virbac operates in the animal health sector, providing a range of health solutions for animals.
